Recombinant antibody production utilizes Chinese hamster ovary (CHO) cells due to their efficiency in expressing complex proteins. Optimizing these processes involves adjusting various factors, including cell line engineering, media ingredients, and bioreactor conditions. A key goal is to increase antibody yield while reducing production financial